Startup India Government of India
Jcre Meds Private Limited
Jcre Meds Private Limited - business services in Imphal, Manipur, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹53.68 Lakh
▲ 266% YoY
Net profit · FY 2025
₹1.84 Lakh
Net margin 3.4%
EBITDA · FY 2025
₹2.83 Lakh
EBITDA margin 5.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.74 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
GST registrations
1
None active
About Jcre Meds Private Limited
Data last updated:
Jcre Meds Private Limited is a private limited company based in Imphal, Manipur, India, recognised as a startup by DPIIT. It was incorporated on 10 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U86909MN2018PTC013731. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.74 Lakh. It was formerly known as Leichin Global Fashion Private Limited. It is led by directors Lairenjam Niranjan Singh and Jayshree Koijam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 118 Thangmeiband Mesnam Leikai Opp Thau Ground, Imphal, Manipur, India – 795001.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.68 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.84 Lakh (net margin 3.4%) and EBITDA of ₹2.83 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 63% over three years and 31% over five years.
Jcre Meds Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MN-05-0007578).
Company details
CIN U86909MN2018PTC013731
Registration Number 013731
Incorporation Date 10 September 2018
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MN-05-0007578
CIN history
Jcre Meds has one previous CIN (Corporate Identification Number): U18209MN2018PTC013731. The current CIN is U86909MN2018PTC013731, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U86909MN2018PTC013731 | Current |
| U18209MN2018PTC013731 | Previous |
Recognitions & Rankings of Jcre Meds
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MN-05-0007578
Contact details
Jcre Meds Private Limited's registered office is in Imphal, Manipur. Its e-mail address is in the company report.
- Email
- Registered Address118 Thangmeiband Mesnam Leikai Opp Thau Ground, Imphal, Manipur, India – 795001
To see the full contact details of Jcre Meds Private Limited, buy the company report.
Comprehensive company report
Jcre Meds Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Jcre Meds is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Jcre Meds Private Limited, buy the company report.
Financials of Jcre Meds Private Limited
FY 2025 filings availableJcre Meds Private Limited reported revenue of ₹53.68 Lakh (up 266% YoY) for FY 2025.
Revenue · FY 2025
₹53.68 Lakh ▲ 266%
Net profit · FY 2025
₹1.84 Lakh margin 3.4%
EBITDA · FY 2025
₹2.83 Lakh margin 5.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 266%
3 years · compounded
▲ 63%
5 years · compounded
▲ 31%
EBITDA CAGR growth
1 year
▲ 402%
3 years · compounded
▲ 81%
5 years · compounded
▲ 133%
Revenue has grown at a compounded annual rate (CAGR) of 31% over five years, including 266% growth in the latest year. EBITDA rose 402% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jcre Meds Private Limited, buy the company report.
Board of directors of Jcre Meds Private Limited
Jcre Meds has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lairenjam Niranjan Singh | Director | 10 Sep 2018 | 8 Years 1 Months | Current |
| Jayshree Koijam | Director | 11 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Jcre Meds Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Billionlives Integrated Healthcare Private Limited | ₹53.92 Lakh (FY 2025) | 10.0% | Chennai, Tamil Nadu, India | |||
| Life Save Ems Private Limited | ₹53.81 Lakh (FY 2020) | Alappuzha, Kerala, India | ||||
| Jcre Meds Private Limitedthis company | ₹53.68 Lakh (FY 2025) | ₹1.84 Lakh | 3.4% | 266.0% | Imphal, Manipur, India | |
| Anuveda Life Sciences Private Limited | ₹53.24 Lakh (FY 2024) | -68.0% | Pune, Maharashtra, India |
To see the full peer comparison of Jcre Meds Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jcre Meds Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jcre Meds Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jcre Meds has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Jcre Meds Private Limited, buy the company report.
Recent activity
Jcre Meds Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Jitendra Kumar Jain ceased to be Director on 18 Jan 2021.
AGM
Jcre Meds Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jcre Meds Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati.
Ceased
Jitendra Kumar Jain ceased to be Director.
Appointed
Jayshree Koijam was appointed as Director.
Appointed
Lairenjam Niranjan Singh was appointed as Director.
Incorporation
10 Sep 2018
Jcre Meds Private Limited was registered on 10 Sep 2018 with Roc Guwahati & aged 8 years 2 months as per MCA records.
Frequently asked questions
Jcre Meds is an active private limited company based in Imphal, Manipur, India. It was incorporated on 10 September 2018 (8+ years old) and is registered under CIN U86909MN2018PTC013731.
Jcre Meds has 2 current directors:
- Lairenjam Niranjan Singh - Director
- Jayshree Koijam - Director
The latest financial statements of Jcre Meds on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
No. Jcre Meds has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Jcre Meds is U86909MN2018PTC013731. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jcre Meds was incorporated on 10 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Jcre Meds by revenue are Billionlives Integrated Healthcare Private Limited, Life Save Ems Private Limited, Anuveda Life Sciences Private Limited, all in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities).
Jitendra Kumar Jain ceased to be Director on 18 Jan 2021. Jayshree Koijam was appointed as Director on 11 Jan 2021. Lairenjam Niranjan Singh was appointed as Director on 10 Sep 2018.
Yes, Jcre Meds is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Jcre Meds is registered as a micro enterprise under Udyam registration (number: UDYAM-MN-05-0007578).
The registered office of Jcre Meds is at 118 Thangmeiband Mesnam Leikai Opp Thau Ground, Imphal, Manipur, India – 795001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages